NCT02752204 - An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 7, 2017

Study Completion Date

February 6, 2020

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG

AZD 2014

AZD2014 125mg BD - 2 days on 5 days off in a 28 day cycle

DRUG

Rituximab

Rituximab 375mg/m2 will be administered intravenously on day 1 of a 28 day cycle for a total of 6 cycles.

Trial Locations (9)

Aberdeen Royal Infirmary, Aberdeen

Royal Liverpool University Hospital, Liverpool

University College London Hospitals, London

Guys Hospital, London

The Christie NHS Foundation Trust, Manchester

Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich

The Churchill Hospital, Oxford

Derriford Hospital, Plymouth

University Hospital Southampton NHS Foundation Trust, Southampton